1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Canine |
Cat.No | ABC-H0096X |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | DC Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Bone Marrow |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Canine Primary Cells |
Canine Bone Marrow Dendritic Cells are primary immune cells isolated from the femurs and tibias of healthy male and female beagle dogs. In vitro, they are non-adherent and short-lived. They are derived from hematopoietic progenitors and differentiated using GM-CSF or Flt3L. Cells express CD4, CD8, CD1c, CD11b, CD11c, and CD14, detected by flow cytometry or immunofluorescence. LPS stimulation induces MHC-II and co-stimulatory molecule expression. Karyotype analysis has not been reported. They are non-tumorigenic and non-metastatic, free of Mycoplasma, bacteria, fungi, yeast, and tested negative for canine-specific viruses like CDV and CAV. These cells are ideal for veterinary immunology and translational antigen-presentation studies under BSL-2 conditions.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Canine Bone Marrow Dendritic Cells (caDC) are valuable for investigating immune-mediated diseases, graft rejections, and cancers in canine models for immune-mediated diseases, graft rejections, and cancers. Characterizing caDC subsets and their role in inflammation and immune responses is crucial for advancing veterinary immunology.Furthermore, they show promise as a novel immunotherapy for canine cancers, as they can be induced to stimulate tumor-specific CD8 T cells, opening avenues for innovative and targeted therapeutic approaches in veterinary oncology.